Rise Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Rise Advisors, LLC
- $207 Million
- Q3 2024
A detailed history of Rise Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 50 shares of CRL stock, worth $9,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$9,200
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
721Shares Held
52MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.12 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$936 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$384 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$351 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$324 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.36B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...